To learn more about this report, Tirzepatide Market Insights, By Dosage Form Single-dose Pen Leads due to Patient Convenience and Accuracy In terms of dosage form, single-dose pen is expected to contribute 59.8% share of the global Tirzepatide market largely due to its ease of use, portability, and dosing accuracy, attributes that are especially valued in chronic treatments requiring regular administration
Formulation can improve both stability and absorption, but even with the most advanced formulation, the only oral GLP-1 available today achieves roughly one percent absorption, and uptake varies widely between patients, making consistent dosing a challenge
All medications come from licensed 503A compounding pharmacies and are available in all 50 states without insurance requirements
A startup pharmacy in Washington, owned by Mochi Health, is under investigation after whistleblowers alleged it allowed unlicensed workers to handle and package compounded GLP-1 weight-loss drugs in violation of state law
